HIGHLIGHTS
- who: Rita Barone et al. from the University of Catania, Catania, Italy have published the paper: Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder, in the Journal: (JOURNAL)
- what: The study showed aberrations in histone acetylation in the prefrontal and temporal cortex of patients with ASD.
- future: Future studies in this domain might be directed toward testing the occurrence of allelic variations responsible for heat inactivation of CPT2 and other pivotal components of ATP generation through mtFAO. Although safety profiles of TZD were documented in young . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.